Skip to main navigation Skip to search Skip to main content

Tumor Kinetic and Survival/Dropout Modeling of Durvalumab for Multiple Cancer Types

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date05/16/19 → 05/15/21

Funding

  • MedImmune: $39,764.00